Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)

PHASE3CompletedINTERVENTIONAL
Enrollment

740

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions
Chronic Low Back Pain
Interventions
DRUG

Oxycodone DETERx

40-160 mg total daily dose of oxycodone DETERx, divided into 2 doses, q12h

DRUG

Placebo

Placebo, divided into 2 doses, q12h

Trial Locations (45)

10128

New York

14221

Williamsville

14618

Rochester

19139

Philadelphia

24018

Roanoke

27103

Winston-Salem

29406

Charleston

30060

Marietta

31904

Columbus

32720

DeLand

32860

Orlando

33317

Plantation

33409

West Palm Beach

34108

Naples

37825

New Tazewell

39581

Pascagoula

45242

Cincinnati

46203

Indianapolis

46383

Valparaiso

57702

Rapid City

63128

St Louis

66211

Overland Park

73116

Oklahoma City

75230

Dallas

77098

Houston

78731

Austin

84058

Orem

84106

Salt Lake City

85050

Phoenix

85282

Mesa

85704

Tucson

89123

Las Vegas

90620

Buena Park

90703

Cerritos

91105

Pasadena

91942

La Mesa

92025

Escondido

92801

Anaheim

92804

Anaheim

94558

Napa

98007

Bellevue

02301

Brockton

01760

Natick

02472

Watertown

08009

Berlin

Sponsors
All Listed Sponsors
lead

Collegium Pharmaceutical, Inc.

INDUSTRY

NCT01685684 - Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP) | Biotech Hunter | Biotech Hunter